We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Computer-Assisted HIV Prevention for Young Drug Users

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2008 by National Development and Research Institutes, Inc..
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00182585
First Posted: September 16, 2005
Last Update Posted: August 13, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center
Information provided by:
National Development and Research Institutes, Inc.
  Purpose
In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Condition Intervention
HIV Procedure: computer-based HIV, STD & Hepatitis Education Procedure: educator-delivered HIV, STD and Hepatitis education

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Computer-Assisted HIV Prevention for Young Drug Users

Resource links provided by NLM:


Further study details as provided by National Development and Research Institutes, Inc.:

Primary Outcome Measures:
  • HIV risk behavior

Secondary Outcome Measures:
  • knowledge related to HIV, Hepatitis, STDs
  • behavioral intentions
  • attitudes toward risk-reduction behavior
  • feedback on intervention

Estimated Enrollment: 56
Study Start Date: August 2004
Detailed Description:
Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aadolescents in outpatients substance abuse treatment
  • Ages 13 - 18 years
  • Within first month of treatment entry

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00182585


Locations
United States, New York
Daytop
Brooklyn, New York, United States, 11217
St. Luke's-Hospital, CAPA Program
New York, New York, United States, 10025
Sponsors and Collaborators
National Development and Research Institutes, Inc.
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Lisa Marsch, PhD National Development and Research Institutes, Inc.
  More Information

ClinicalTrials.gov Identifier: NCT00182585     History of Changes
Other Study ID Numbers: R01DA015964 ( U.S. NIH Grant/Contract )
First Submitted: September 10, 2005
First Posted: September 16, 2005
Last Update Posted: August 13, 2008
Last Verified: August 2008

Keywords provided by National Development and Research Institutes, Inc.:
HIV
hepatitis
STDs
adolescents
addiction
treatment
prevention
HIV and related risk behavior among youth in drug treatment


To Top